1. Anticoagulant therapy and TEVAR in a patient with antiphospholipid syndrome presenting with pulmonary embolisms and multiple arterial embolisms due to thoracic aortic mural thrombosis
- Author
-
Ryosuke Tani, Kaoru Mantani, Tetsuo Minamino, Yoichi Yamashita, Takahisa Noma, Waki Toyama, Taiko Horii, and Keiji Matsunaga
- Subjects
medicine.medical_specialty ,Thoracic endovascular aortic repair ,Computed tomography ,030204 cardiovascular system & hematology ,Thoracic aortic mural thrombus ,Article ,03 medical and health sciences ,0302 clinical medicine ,Antiphospholipid syndrome ,Internal medicine ,medicine ,In patient ,cardiovascular diseases ,030212 general & internal medicine ,Artificial materials ,medicine.diagnostic_test ,business.industry ,Leg pain ,medicine.disease ,Anticoagulant therapy ,Mural thrombosis ,cardiovascular system ,Cardiology ,Cardiology and Cardiovascular Medicine ,business ,Aortic thrombosis - Abstract
We often observe patients with antiphospholipid syndrome (APS) presenting with both venous and arterial thrombi. Anticoagulant therapy is effective for venous and peripheral arterial embolisms in these patients; however, it has opposite effects when applied for thoracic aortic mural thrombosis because of the risk of new arterial embolisms. Recently, thoracic endovascular aortic repair (TEVAR) has been used to prevent arterial embolisms due to aortic thrombosis. However, we generally hesitate to implant artificial materials in patients in a hypercoagulable state because this can cause new thrombi to develop. Here, we present a case of successful treatment by anticoagulant therapy and TEVAR in an APS patient presenting with pulmonary embolisms (PEs) and multiple arterial embolisms due to thoracic aortic mural thrombosis. A 46-year-old man was referred to our hospital due to dyspnea and leg pain. Since contrast-enhanced computed tomography revealed PEs, thoracic aortic mural thrombosis, and lower limb arterial embolisms, we administered anticoagulation therapy. Three days later, contrast-enhanced computed tomography revealed new arterial embolisms in the right kidney. To prevent further arterial embolisms due to thoracic aortic mural thrombosis, we performed emergent TEVAR in addition to anticoagulant therapy. Thereafter, no venous or arterial embolisms recurred during the 13-month follow-up period.
- Published
- 2019